A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

Status:
Recruiting

Trial end date:
2022-09-29

Target enrollment:

Participant gender:

The main purpose of the study is to assess the effect of LY3502970 in participants who have obesity or are overweight

Phase 2

Eli Lilly and Company